Home
About Us
Business Strategy
Mission and Values
History
Management Team
Board of Directors
Technology
Multikine
What is Multikine
Clinical Trial Status
Phase 3 Trial Design
Mechanism of Action
Potential Indications
Key Publications
Leaps
What is LEAPS
Scientific Backgrounder
Key Publications
Product Pipeline
Investors
SEC Filings
Stock Chart & Fundamentals
Corporate Governance
Corporate Presentations
News
Sign Up For News
Careers
Contact
CEL-SCI CORPORATION RELEASES LETTER TO SHAREHOLDERS
CEL-SCI ANNOUNCES THAT THE NYSE AMERICAN APPROVES PLAN
August 29, 2018
CEL-SCI ANNOUNCES WARRANTS TO EXPIRE ON OCTOBER 11, 2018
October 21, 2018
0
brandonschwartz32@gmail.com
Related posts
August 29, 2018
CEL-SCI ANNOUNCES THAT THE NYSE AMERICAN APPROVES PLAN
Read more
August 29, 2018
CEL-SCI CORPORATION RELEASES LETTER TO SHAREHOLDERS
Read more
Comments are closed.
Close
Font Resize
A-
A+
Readable Font
Clear cookies
Images Greyscale
Invert Colors
Remove Animations
Close
Accessibility by WAH
